Single Molecule Counting Tech Firm Singulex Secures $55M in Financing | GenomeWeb

NEW YORK (GenomeWeb News) – Singulex today announced it secured $55 million in debt and equity financing.

The company secured a $40 million debt facility from Oxford Finance and Silicon Valley Bank, and in June, it raised $15 million in equity financing. Singulex said it plans to use the financing to further develop its in vitro diagnostics business based on its Single Molecule Counting technology.

The Alameda, Calif.-based company raised $19 million in a financing round in January 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.